Clinical Trials in Nashville

Showing 7121-7140 of 15,379 trials

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

NCT01951417

This is an open-label, multi-center study to be conducted in the United States. The study will examine the change in lesion count in subjects using Epiduo® Gel Pump (once daily) in conjunction with Cetaphil® DermaControl™ Foam Wash (twice daily) and Moisturizer SPF 30 (once daily). Subjects with a clinical diagnosis of mild or moderate acne who are eligible for treatment with Epiduo® in accordance with the currently approved product labeling and who meet other inclusion/exclusion criteria are to be enrolled in the study and receive the study products for 8 weeks. Efficacy and safety assessments include: complete lesion counts, cutaneous irritation assessment, end of study treatment questionnaire, photographic evaluation for oiliness, skin tone, and P Acnes, hydration assessment, barrier function assessment, treatment compliance, and adverse event assessment.

Acne

Galderma R&D81 participantsStarted Oct 2013

Boynton Beach, Florida, United States • Nashville, Tennessee, United States • Carrollton, Texas, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

NCT00763555

This was a multicenter, randomized, vehicle-controlled, double-blind parallel group study to evaluate the efficacy and safety of CD 2027 Oily Spray applied twice daily for 8 weeks in participants with plaque-type psoriasis.

Psoriasis

Galderma R&D88 participantsStarted Sep 2008

Fridley, Minnesota, United States • Nashville, Tennessee, United States • Edmonton, Alberta, Canada +3 more locations

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

Find Trials by Condition in Nashville

3T MRI CIED Post-Approval Study

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation